English中文

Offstream
news


Fatah–Hamas reconciliation process

Palestinian factions, Hamas and Fatah, sign a unity deal in Cairo, that is also publicly supported by the governments of Egypt and Saudi Arabia. The Fatah-controlled Palestinian National Authority (PNA), along with Israel, currently govern the West Bank. According to the signatories of the deal, the PNA will take administrative control of the Gaza Strip, and, along with Hamas, police its borders. The signatories consider the agreement a first step, and, if productive, plan to meet next month to address the remaining issues. The government of Israel opposes any involvement by Hamas in a Palestinian government.

Gene therapy

A panel of external experts to the U.S. Food and Drug Administration unanimously vote that the benefits of the gene replacement treatment made by Spark Therapeutics of Philadelphia, Pennsylvania, called voretigene neparvovec (trade name, Luxturna), which treats Leber's congenital amaurosis (LCA), a form of hereditary blindness, outweigh its risks. The treatment, which targets a specific disease-causing mutation, is designed to treat individuals who have two mutated copies of a gene called "RPE65" and consists of a virus injected into the eye loaded with a normal copy of the "RPE65" gene. Further, this technique utilizing adeno-associated virus as a vector may, in the future, be used for the treatment of heart disease and also mutations other than LCA, including some cancers.